Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Rang în acțiuni #30251
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Preț acțiune
$1.88
Ultima sincronizare: 2026-08-18
Capitalizare de piață
$17.59M
Schimbare (1 zi)
0.81%
Schimbare (1 an)
-92.40%
Țară
US
Tranzacționează Tvardi Therapeutics, Inc. (TVRD)

Categorie

Istoric al prețului acțiunii pentru Tvardi Therapeutics, Inc. (TVRD)
Cel mai mare preț de închidere: $1.83 pe 2026-08-01

Cel mai mic preț de închidere: $17.54 pe 2025-04-01
Istoric al prețului acțiunii pentru Tvardi Therapeutics, Inc. din 2025 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 100.99%
2025 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$527.89 35.09%
US
$996.61 51.72%
NL
$115.52 -20.64%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE